Editorial: Novel Small-Molecule Agents in Overcoming Multidrug Resistance in Cancers

por Cui, Qingbin, Wang, Cong, Zeng, Leli, Zhou, Qian-Xiong, Fan, Ying-Fang
Publicado 2022

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

por Zeng, Leli, Chen, Yu, Liu, Jiangping, Huang, Huaiyi, Guan, Ruilin, Ji, Liangnian, Chao, Hui
Publicado 2016

APY0201 Represses Tumor Growth through Inhibiting Autophagy in Gastric Cancer Cells

por Li, Huan, Jin, Xinghan, Zhang, Shiwei, Li, Bo, Zeng, Leli, He, Yulong, Zhang, Changhua
Publicado 2022

Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line

por Wu, Zhuo-Xun, Yang, Yuqi, Zeng, Leli, Patel, Harsh, Bo, Letao, Lin, Lusheng, Chen, Zhe-Sheng
Publicado 2021

Deletion of Wild-type p53 Facilitates Bone Metastatic Function by Blocking the AIP4 Mediated Ligand-Induced Degradation of CXCR4

por Li, Qiji, Wang, Min, Zeng, Leli, Guo, Wei, Xu, Yuandong, Li, Chenxin, Lai, Yingrong, Ye, Liping, Peng, Xinsheng
Publicado 2022

Combining Organoid Models with Next-Generation Sequencing to Reveal Tumor Heterogeneity and Predict Therapeutic Response in Breast Cancer

por Liu, Yuhong, Gan, Yixiang, AiErken, NiJiati, Chen, Wei, Zhang, Shiwei, Ouyang, Jie, Zeng, Leli, Tang, Di
Publicado 2022

Enhanced mild-temperature photothermal therapy by pyroptosis-boosted ATP deprivation with biodegradable nanoformulation

por Liu, Kaiyuan, Zhang, Li, Lu, Hengli, Wen, Yingfei, Bi, Bo, Wang, Guocheng, Jiang, Yingying, Zeng, Leli, Zhao, Jing
Publicado 2023

Understanding and targeting resistance mechanisms in cancer

por Lei, Zi‐Ning, Tian, Qin, Teng, Qiu‐Xu, Wurpel, John N. D., Zeng, Leli, Pan, Yihang, Chen, Zhe‐Sheng
Publicado 2023

Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications

por Song, Huibin, Liu, Dongcheng, Dong, Shaowei, Zeng, Leli, Wu, Zhuoxun, Zhao, Pan, Zhang, Litu, Chen, Zhe-Sheng, Zou, Chang
Publicado 2020

Oncosis-inducing cyclometalated iridium(iii) complexes

por Guan, Ruilin, Chen, Yu, Zeng, Leli, Rees, Thomas W., Jin, Chengzhi, Huang, Juanjuan, Chen, Zhe-Sheng, Ji, Liangnian, Chao, Hui
Publicado 2018

Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study

por Fang, Shuo, Liu, Yuchen, Dai, Huiru, Gao, Tianshun, Zeng, Leli, Sun, Rui, Zheng, Zilong, Yuan, Jinqiu, Xia, Bin, Pan, Yihang
Publicado 2022

Long non-coding RNAs regulate drug resistance in cancer

por Liu, Kaisheng, Gao, Lin, Ma, Xiaoshi, Huang, Juan-Juan, Chen, Juan, Zeng, Leli, Ashby, Charles R., Zou, Chang, Chen, Zhe-Sheng
Publicado 2020

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor

por Wu, Zhuo-Xun, Yang, Yuqi, Wang, Jing-Quan, Narayanan, Silpa, Lei, Zi-Ning, Teng, Qiu-Xu, Zeng, Leli, Chen, Zhe-Sheng
Publicado 2021

Advancements in nanoparticle-based treatment approaches for skin cancer therapy

por Zeng, Leli, Gowda, B. H. Jaswanth, Ahmed, Mohammed Gulzar, Abourehab, Mohammed A. S., Chen, Zhe-Sheng, Zhang, Changhua, Li, Jia, Kesharwani, Prashant
Publicado 2023

Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA‒miRNA-mRNA ceRNA network

por Deng, Cuncan, Peng, Juzheng, Yuan, Cheng, Li, Huafu, Li, Wenchao, Chu, Hongwu, Wei, Hongfa, He, Yulong, Zeng, Leli, Huo, Mingyu, Zhang, Changhua
Publicado 2023

Engineering Bifunctional Calcium Alendronate Gene‐Delivery Nanoneedle for Synergistic Chemo/Immuno‐Therapy Against HER2 Positive Ovarian Cancer

por Chen, Guochuang, Zeng, Leli, Bi, Bo, Huang, Xiuyu, Qiu, Miaojuan, Chen, Ping, Chen, Zhi‐Ying, He, Yulong, Pan, Yihang, Chen, Yu, Zhao, Jing
Publicado 2023

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

por Zhang, Wei, Fan, Ying-Fang, Cai, Chao-Yun, Wang, Jing-Quan, Teng, Qiu-Xu, Lei, Zi-Ning, Zeng, Leli, Gupta, Pranav, Chen, Zhe-Sheng
Publicado 2018

Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells

por Zhang, Xiao-Yu, Zhang, Yun-Kai, Wang, Yi-Jun, Gupta, Pranav, Zeng, Leli, Xu, Megan, Wang, Xiu-Qi, Yang, Dong-Hua, Chen, Zhe-Sheng
Publicado 2016

Signaling pathways and therapeutic interventions in gastric cancer

por Lei, Zi-Ning, Teng, Qiu-Xu, Tian, Qin, Chen, Wei, Xie, Yuhao, Wu, Kaiming, Zeng, Qianlin, Zeng, Leli, Pan, Yihang, Chen, Zhe-Sheng, He, Yulong
Publicado 2022

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

por Wang, Jing-Quan, Li, Jonathan Y., Teng, Qiu-Xu, Lei, Zi-Ning, Ji, Ning, Cui, Qingbin, Zeng, Leli, Pan, Yihang, Yang, Dong-Hua, Chen, Zhe-Sheng
Publicado 2020